DHAKA, May 3, 2020 (BSS) – Unilever Bangladesh has signed a memorandum of
understanding with International Centre for Diarrhoeal Disease Research,
Bangladesh (icddr,b) to strengthen its ongoing COVID-19 emergency response.
Unilever Bangladesh will provide $ 52,000 cash support for personal
protective equipments to icddr,b’s clinical laboratory services, and
establishment of a temporary patient care facility, said a press release
today.
Additionally, Unilever Bangladesh will provide its health and hygiene
products, medical and lab equipments, and COVID-19 testing kits to icddr,b.
Unilever Bangladesh already pledged Taka 200 million to help the nation in
its fight against COVID-19.
The commitment includes product donations, creating awareness, improving
health infrastructure, protecting its people and livelihoods.
icddr,b is also implementing global best practices and safety protocols for
its own care givers, researchers and staffs for ensuring the continuity of
its free of charge diarrhoeal disease treatment and other essential research
activities even during the ongoing global pandemic.
Moreover, as part of icddr,b’s commitment to solve public health
challenges, it is also planning on interventions and epidemiological research
related to Covid-19.
icddr,b’s Executive Director Professor John D Clemens said “It is our
honour to serve the people of Bangladesh during this unparalleled time of
need.”
Chief Executive Officer and Managing Director of Unilever Bangladesh Kedar
Lele said “It is our responsibility to reach out to as many people as
possible and help them in their fight against the virus. Considering the
scale of the challenge and in order to address it at multiple levels, we are
collaborating with the government, health institutions, implementation
partners and civil society.”